Subtyping depression in the rheumatic diseases by cluster analysis
Clinical Rheumatology · 2025-09 · 44 (9) · 3743-3751
DOI: 10.1007/s10067-025-07586-7 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Rheumatology, online erschienen am 21.07.2025. Verfasst von Yaqi Zhao und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology and Immunology, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China. Hauptthemen laut MEDLINE: Rheumatic Diseases, Major Depressive Disorder, Depression. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: Innovative Research Group Project of the National Natural Science Foundation of China, Natural Science Foundation of Shandong Province.
Themen: Depression
Abstract (Originalsprache)
OBJECTIVE: Major depressive disorder (MDD) and rheumatic diseases (RD) interact to exacerbate disease outcomes. The purpose of this study was to assess the prevalence and associated factors of depression in RD patients in order to identify independent predictors of mental health disorders risk and apply cluster analysis to identify homogeneous groups in a population of approximately 47 patients with RD-MDD to achieve precise treatment and early prevention of complications. METHODS: In total, 205 RD patients were included in this study. We used the Profile of Mood State (POMS) and Patient Health Questionnaire-9 (PHQ-9) to assess the patients' state of mind. A cluster analysis was applied according to six clinical and serological variables to define different subgroups of patients. RESULTS: The rate of depression in RD patients in our study was 22.9%. Sex (female), disease duration, and disease activity are risk factors for the development of depression. Albumin is a protective factor for MDD. RD-MDD patients were clustered in two groups. Cluster 1 (n = 30, 63.8%): patients were of older age, lower education and income levels, low disease activity, and mild depressive symptoms. Cluster 2 (n = 17, 36.2%): Young women with higher education and income levels, high disease activity, and more severe depressive symptoms. CONCLUSION: Our findings provide evidence indicating that RD-MDD presents varying clinical phenotypes and the treatment varies accordingly, suggesting the need for individualized treatment. Key Points • Depression is often comorbid in patients with rheumatic diseases. The two interact and aggravate the patient's condition. • The rate of depression in RD patients in our study was 22.9%. Sex (female), disease duration, and disease activity are risk factors for the development of depression. Albumin is a protective factor for MDD. • RD-MDD patients were clustered in two groups through cluster analysis in order to guide individualized treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Rheumatology and Immunology, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China.
- Department of Rheumatology and Immunology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China.
- Department of Rheumatology and Immunology, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China. mazhenzhendz@163.com.
- Department of Rheumatology and Immunology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China. mazhenzhendz@163.com.
- Department of Rheumatology and Immunology, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China. qryang720@163.com.
- Department of Rheumatology and Immunology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China. qryang720@163.com.
Förderung
- Innovative Research Group Project of the National Natural Science Foundation of China
- Natural Science Foundation of Shandong Province
Zitieren
APA
Zhao, Y., Yan, S., Li, X., Xu, W., Liu, B., Ma, Z., & Yang, Q. (2025). Subtyping depression in the rheumatic diseases by cluster analysis. Clinical Rheumatology, 44(9), 3743-3751. https://doi.org/10.1007/s10067-025-07586-7
Vancouver
Zhao Y, Yan S, Li X, Xu W, Liu B, Ma Z, et al. Subtyping depression in the rheumatic diseases by cluster analysis. Clinical Rheumatology. 2025;44(9):3743-3751. doi:10.1007/s10067-025-07586-7
BibTeX
@article{Zhao2025,
author = {Zhao, Yaqi and Yan, Suyan and Li, Xinya and Xu, Wei and Liu, Baocheng and Ma, Zhenzhen and Yang, Qingrui},
title = {Subtyping depression in the rheumatic diseases by cluster analysis},
journal = {Clinical Rheumatology},
year = {2025},
volume = {44},
number = {9},
pages = {3743--3751},
doi = {10.1007/s10067-025-07586-7}
}
EUVIMED